Cognition After OSA Treatment Among Native American People (CATNAP)
Launched by WASHINGTON STATE UNIVERSITY · Jan 25, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The CATNAP trial is a research study aimed at improving the health and memory of American Indian elders who have been diagnosed with obstructive sleep apnea (OSA). OSA is a condition that causes breathing problems during sleep, which can affect overall health and may increase the risk of developing Alzheimer's disease and other forms of dementia. In this study, participants aged 50 and older from three Northern Plains Reservations will be divided into two groups. One group will receive standard care with their prescribed breathing device, while the other group will receive additional support through motivational interviewing and electronic messaging that is tailored to their cultural background.
To participate in this study, individuals must be at least 50 years old, identify as American Indian or Alaskan Native, and have been diagnosed with OSA and prescribed a breathing device called a PAP machine. They should also be able to understand English and be willing to follow the study guidelines. Participants can expect to receive either standard care or the extra support aimed at encouraging better use of their PAP therapy, which is crucial for managing their condition. This trial is currently recruiting, and it offers a unique opportunity for elders to potentially improve their sleep health and cognitive function while contributing to important research in their community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 50 years and older
- • Self report American Indian or Alaskan Native
- • diagnosed with obstructive sleep apnea
- • prescribed PAP therapy and have a device
- • \*Ability to understand written and spoken English; and
- • \*Ability and willingness to follow all study protocols.
- Exclusion Criteria:
- • Living in a household with someone who is enrolled in the study
- • Already using PAP device at Medicaid recommended standards
- • Cognitive decline, unable to consent on their own
About Washington State University
Washington State University (WSU) is a leading research institution committed to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on interdisciplinary collaboration, WSU leverages its diverse expertise across various fields, including medicine, engineering, and agriculture, to address pressing health challenges. The university's clinical trial programs aim to enhance patient outcomes and contribute to the development of new therapies and interventions. By fostering a culture of scientific inquiry and integrity, WSU strives to improve public health and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Eagle Butte, South Dakota, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported